Antibodies Against GPCR

Abstract

G-protein-coupled receptors (GPCRs) are the largest family of receptors in humans. GPCRs are seven-transmembrane receptors that are activated by the binding  of a ligand to the extracellular domain. In addition to the endogenous ligands,  auto-antibodies (aab) can also bind to the GPCRs. They can activate different and  specific cellular pathways which contribute to various diseases. In this review,  the authors summarize the knowledge about antibodies targeting GPCRs and their  effects and relevance in the pathogenesis of various diseases and their use in  clinical diagnostics. We highlight the role of different activating anti-GPCR aab  in solid organ transplantations, stem cell transplantations, systemic sclerosis,  preeclampsia, chronic fatigue syndrome, cardiovascular diseases, Alzheimer's  disease, and cancer.